12:00 AM
Feb 11, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Status

ASP8232: Phase I started

Astellas said in its 3Q12 earnings ending Dec. 31, 2012, that it began a...

Read the full 50 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >